New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Roche Holding AG
RHHVF
Shape
US Flag

PNK

254B

Drug Manufacturers - General

Next Earning date - 11 Dec 2024

254B

Drug Manufacturers - General

Next Earning date - 11 Dec 2024

314.35USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

8%

Quote Panel

Shape
Updated October 3, 2024
1W -2.38 % 1M -4.74 % 3M 16.34 % 1Y 21.98 %

Key Metrics

Shape
  • Market Cap

    253.94B


  • Shares Outstanding

    807.81M


  • Share in Float

    796.04M


  • Dividende

    10.86


  • Earning Date

    11 Dec 2024


  • Price Target

    314.35


  • Average Volume

    8901


  • Beta

    0.148


  • Range

    233.12-340.88


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.roche.com


  • Sector

    Healthcare


Fundamentals

Shape

17.45x

P/E Ratio

2.43x

P/S Ratio

7.39x

P/B Ratio

1.2

Debt/Equity

17.9%

Net Margin

$15.7

EPS

How RHHVF compares to sector?

P/E Ratio

Relative Strength

Shape

RHHVF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$76B

Shape153%

2025-Revenue

$20.13

Shape156%

2025-EPS

$27B

Shape136%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

10.99
vs NA

Q3.22

arrow
arrow

N/A

2.45
vs NA

Q4.22

arrow
arrow

N/A

5.26
vs NA

Q1.23

arrow
arrow

N/A

4.84
vs NA

Q2.23

arrow
arrow

-10%

9.9
vs 10.99

Q3.23

arrow
arrow

+21%

2.96
vs 2.45

Q4.23

arrow
arrow

+21%

6.34
vs 5.26

Q1.24

arrow
arrow

N/A

NA
vs 4.84

Q2.24

arrow
arrow

-12%

8.71
vs 9.9

Q4.24

arrow
arrow

+29%

8.19
vs 6.34

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+5%

32.3B  vs 30.7B

Q3.22

arrow
arrow

-5%

16B  vs 16.9B

Q4.22

arrow
arrow

-3%

31B  vs 32.1B

Q1.23

arrow
arrow

-10%

15.3B  vs 16.9B

Q2.23

arrow
arrow

-8%

29.8B  vs 32.3B

Q3.23

arrow
arrow

-7%

14.9B  vs 16B

Q4.23

arrow
arrow

-7%

28.9B  vs 31B

Q1.24

arrow
arrow

+0%

15.4B  vs 15.3B

Q2.24

arrow
arrow

+0%

29.8B  vs 29.8B

Q4.24

arrow
arrow

-9%

26.3B  vs 28.9B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+7%

0.07
vs 0.34

Q4.22

arrow
arrow

+14%

0.14
vs 0.07

Q1.23

arrow
arrow

+13%

0.13
vs 0.14

Q2.23

arrow
arrow

+27%

0.27
vs 0.13

Q3.23

arrow
arrow

+7%

0.07
vs 0.27

Q4.23

arrow
arrow

+15%

0.15
vs 0.07

Q1.24

arrow
arrow

+11%

0.11
vs 0.15

Q2.24

arrow
arrow

+22%

0.22
vs 0.11

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News